UNSPSC 85613222: Supplement pancreatic duct with nonautologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement pancreatic duct with nonautologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0FUD4KZ

UNSPSC 85613222 Supplement pancreatic duct with nonautologous tissue substitute, percutaneous endoscopic approach (Commodity) shows no relevant recent state and local procurement activity. The six most recent opportunities tagged to this code are medical evaluation services, health plan surgical benefits, occupational medical surveillance, juvenile detention healthcare, pharmacy benefit management, and temporary health professional staffing—none of which involve pancreatic duct supplementation or the specialized surgical procedure the code nominates. The mismatch between the code's clinical scope and the actual work being solicited suggests either miscoding in the state and local procurement systems or that this particular procedure tier sees little to no recurring purchasing activity at the state and local level.

State and local buyers appear to use this Commodity code infrequently if at all for their actual healthcare contracting. Activity under the broader Family or Class tier that encompasses occupational and employee health services is far more robust; buyers at county health systems, city retirement offices, and state transportation agencies are actively soliciting medical evaluation, surveillance, and benefit administration services. Vendors pursuing healthcare-related work with state and local bodies should monitor the parent Family and Class codes rather than this narrowly defined Commodity code.